What’s clear from a debate here at the Technology and Heart Failure Therapeutics (THT) 2023 meeting is that the choice to move forward with advanced HF care versus transcatheter edge-to-edge repair ...

Boston, MA—When it comes to choosing between transcatheter edge-to-edge repair (TEER) or guideline-directed medical therapy for tricuspid regurgitation (TR) for the most severely ill patients, the ...

In February, the FDA’s Circulatory System Devices Panel voted to recommend the transcatheter edge-to-edge repair (TEER) device (TriClip) for patients with severe tricuspid regurgitation ...

There were fewer 30-day safety events in the TEER group. Perspective from David J. Moliterno, MD, FACC, FACP, FAHA, FESC, FSCAI In patients with HF and secondary mitral regurgitation ...

CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF ...

The only component with a significant difference between groups was KCCQ improvement, with a mean gain of 12.3 points after TEER versus 0.6 points with medical therapy alone (P<0.001).

A life-saving medical procedure called Trans-catheter Edge-to-edge Repair (or TEER) for a common heart complaint is not available to many patients it could help. Terminology on the current NHS ...